// App-Quantinova.ai

e23004 : Biological effects of cabozantinib on bone microenvironment.

Researchers

Presenter

  • Francesco Pantano

Principal Investigators

  • Marco Fioramonti

  • Michele Iuliani

  • Giulia Ribelli

  • Bruno Vincenzi

  • Giuseppe Tonini

  • Daniele Santini

Medical Centers

  • Department of Anatomical Pathology, Campus Bio-Medico University of Rome, Rome, Italy

  • Policlinico Universitario Campus Bio-Medico, Roma, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Twin-reversed arterial perfusion

Biomarkers

  • Alkaline phosphatase

  • Osteoprotegerin

  • Cluster of Differentiation 14

  • Receptor activator of nuclear factor kappa-Β ligand

  • Triiodothyronine receptor auxiliary protein

Drug/Treatment

  • Cabozantinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved